Trial Profile
Randomised, Double-blind, Double-dummy, 52-week, Parallel Group Study of a Standard Dosing Regimen With Salmeterol/Fluticasone propionate50/250 Twice Daily Diskus Versus a Symptom-driven, Variable Dosing Regimen With Formoterol/Budesonide Combination 4.5/160 in Adult Asthmatics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms CONCEPT
- Sponsors GlaxoSmithKline; GSK
- 24 Jan 2011 Additional trial locations identified as reported by ClinicalTrials.gov.
- 28 Jul 2007 New trial record.